Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -82,468 | -46,360 | -20,807 | -18,116 |
| Depreciation Amortization | 1,235 | 873 | 666 | 534 |
| Accounts payable and accrued liabilities | 1,066 | 2,705 | -304 | -465 |
| Other Working Capital | 4,275 | 6,849 | -627 | 289 |
| Other Operating Activity | 8,169 | 5,043 | 951 | 3,058 |
| Operating Cash Flow | $-67,723 | $-30,890 | $-20,121 | $-14,700 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,352 | -993 | -323 | -940 |
| Purchase Of Investment | -105,500 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -60 | 0 |
| Investing Cash Flow | $-106,852 | $-993 | $-383 | $-940 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 118,235 | 128,383 | 457 | 44 |
| Common Stock Repurchased | -90 | -67 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 68,838 | 15,235 |
| Financing Cash Flow | $118,145 | $128,316 | $69,295 | $15,279 |
| Beginning Cash Position | 148,642 | 52,069 | 3,278 | 3,639 |
| End Cash Position | 92,212 | 148,502 | 52,069 | 3,278 |
| Net Cash Flow | $-56,430 | $96,433 | $48,791 | $-361 |
| Free Cash Flow | ||||
| Operating Cash Flow | -67,723 | -30,890 | -20,121 | -14,700 |
| Capital Expenditure | -1,352 | -993 | -323 | -940 |
| Free Cash Flow | -69,075 | -31,883 | -20,444 | -15,640 |